HORIZON PHARMA INVT LTD's ticker is and the CUSIP is 44052TAB7. A total of 32 filers reported holding HORIZON PHARMA INVT LTD in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $3,411,000 | -78.6% | 3,000,000 | -81.2% | 0.31% | -87.7% |
Q4 2018 | $15,929,000 | -1.0% | 16,000,000 | 0.0% | 2.50% | +65.7% |
Q3 2018 | $16,094,000 | +5.1% | 16,000,000 | 0.0% | 1.51% | +9.7% |
Q2 2018 | $15,312,000 | +4.4% | 16,000,000 | 0.0% | 1.38% | +2.2% |
Q1 2018 | $14,672,000 | -1.4% | 16,000,000 | 0.0% | 1.35% | +4.5% |
Q4 2017 | $14,880,000 | +3.0% | 16,000,000 | 0.0% | 1.29% | -12.0% |
Q3 2017 | $14,450,000 | +4.8% | 16,000,000 | 0.0% | 1.47% | -23.4% |
Q2 2017 | $13,790,000 | -5.3% | 16,000,000 | 0.0% | 1.91% | -10.1% |
Q1 2017 | $14,560,000 | -60.8% | 16,000,000 | -59.0% | 2.13% | -76.4% |
Q4 2016 | $37,098,000 | +1.0% | 39,000,000 | +2.6% | 9.02% | +86.7% |
Q3 2016 | $36,741,000 | +1927.6% | 38,000,000 | +1800.0% | 4.83% | +903.7% |
Q2 2016 | $1,812,000 | – | 2,000,000 | – | 0.48% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 136,032,000 | $150,514,000 | 5.41% |
SYMPHONY ASSET MANAGEMENT LLC | 16,000,000 | $17,780,000 | 3.72% |
CSS LLC/IL | 12,427,000 | $13,791,000 | 0.79% |
SSI INVESTMENT MANAGEMENT LLC | 8,793,000 | $9,740,000 | 0.72% |
Worth Venture Partners, LLC | 1,103,000 | $1,227,000 | 0.68% |
ADVENT CAPITAL MANAGEMENT /DE/ | 29,900,000 | $33,208,000 | 0.64% |
Sonora Investment Management, LLC | 4,840,000 | $5,374,000 | 0.60% |
Empyrean Capital Partners, LP | 8,000,000 | $8,875,000 | 0.40% |
DLD Asset Management, LP | 5,500,000 | $6,129,000 | 0.26% |
ARROWGRASS CAPITAL PARTNERS (US) LP | 12,500 | $10,496,000 | 0.25% |